Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Psiquiatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects With Schizophrenia
INTERVENTIONAL
Inicio: 29 de nov de 2021
ID: NCT05110157
Terminado
Fase 3
ClinicalTrials.gov
A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
INTERVENTIONAL
Inicio: 1 de ene de 2017
ID: NCT03121586
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
INTERVENTIONAL
Inicio: 5 de ago de 2020
ID: NCT04531982
Completado
Fase 4
ClinicalTrials.gov
A Phase 4, Non-treatment Follow-up For Cardiac Assessments Following Use Of Smoking Cessation Treatments In Subjects With And Without A History Of Psychiatric Disorders
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01574703
Completado
Fase 4
ClinicalTrials.gov
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
INTERVENTIONAL
Inicio: 1 de nov de 2011
ID: NCT01456936
Aún no recluta
RENIS
J2S-MC-GZMJ: Estudio de Brenipatida en comparación en participantes adultos con trastorno bipolar (RENEW-Bipolar-1)
INTERVENTIONAL
ID: IS005226
Reclutando
RENIS
ALKS 3831-A312 - Estudio de fase III, aleatorizado, doble ciego, de 52 semanas de OLZ/SAM frente a olanzapina para evaluar el aumento de peso según lo evaluado por el cambio en la puntuación Z del IMC en pacientes pediátricos con esquizofrenia o trastorno bipolar I (ENLIGHTEN-Youth)
INTERVENTIONAL
ID: IS004844
Suspendido
RENIS
14865A -Estudio intervencionista, aleatorizado, a doble ciego, de grupos paralelos, controlado con placebo, de dosis flexible, del brexpiprazol como tratamiento complementario a la paroxetina o sertralina en pacientes adultos que sufren trastorno de estrés postraumático (PTSD)
INTERVENTIONAL
ID: IS001151
Completado
RENIS
Estudio sobre la actitud hacia la maternidad y la autopercepción del desempeño del rol materno en mujeres con diagnóstico de trastorno bipolar en tratamiento: Estudio de corte transversal descriptivo y analítico.
OBSERVATIONAL
ID: IS000162
Completado
Fase 3
ClinicalTrials.gov
A Multicenter 26-Week Extension Study to Evaluate the Safety and Clinical Effects of Prolonged Exposure to Two Doses of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, as an Adjunctive Pro-cognitive Treatment in Subjects With Schizophrenia on Chronic Stable Atypical Antipsychotic Therapy
INTERVENTIONAL
Inicio: 1 de jun de 2013
ID: NCT01714713
Completado
ClinicalTrials.gov
Treatment Resistant Depression in America Latina
OBSERVATIONAL
Inicio: 27 de sept de 2017
ID: NCT03207282
Completado
ClinicalTrials.gov
Predicting Factors for Depression in Patients With MS in Argentina
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT01079975
Completado
Fase 3
ClinicalTrials.gov
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients With Schizophrenia
INTERVENTIONAL
Inicio: 24 de jun de 2010
ID: NCT01129882
Terminado
Fase 3
ClinicalTrials.gov
An Open Label, Single Arm, Extension Trial to Examine Long-term Safety of Iclepertin Once Daily in Patients With Schizophrenia Who Have Completed Previous Iclepertin Phase III Trials (CONNEX-X)
INTERVENTIONAL
Inicio: 21 de mar de 2022
ID: NCT05211947
Aún no recluta
Fase 2
ClinicalTrials.gov
A Phase 2 Multicenter, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Adult Participants With Schizophrenia (RENEW-Scz-1)
INTERVENTIONAL
Inicio: 1 de feb de 2026
ID: NCT07410507
Completado
Fase 3
ClinicalTrials.gov
An Open-label Long-term Extension Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression
INTERVENTIONAL
Inicio: 9 de jun de 2016
ID: NCT02782104
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomised, Placebo-controlled, Multicentre, Relapse-prevention Study With Lu AA21004 in Patients With Generalized Anxiety Disorder
INTERVENTIONAL
Inicio: 1 de oct de 2008
ID: NCT00788034
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)
INTERVENTIONAL
Inicio: 30 de jun de 2022
ID: NCT05303064
Completado
Fase 2
ClinicalTrials.gov
A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Major Depressive Disorder (MDD)
INTERVENTIONAL
Inicio: 1 de jun de 2005
ID: NCT00413023
Completado
ClinicalTrials.gov
Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study
OBSERVATIONAL
Inicio: 1 de abr de 2013
ID: NCT02150603
1
2
...
434
Siguiente
Filtros